Evidence map›Paper›PMID 37032353›Full record

ArticleEuropean journal of human genetics : EJHG2023

The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases.

Abderaouf Hamza, Carine El-Sissy, Nadhir Yousfi, Paula Vieira Martins, Cédric Rafat, Julien Masliah-Planchon, Véronique Frémeaux-Bacchi, Laurent Mesnard

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Impact of genome build on RNA-seq interpretation and diagnostics.medRxiv : the preprint server for health sciences · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Abderaouf HamzaDepartment of Genetics, Institut Curie, PSL Research University, Paris, France.ORCID 0000-0001-6977-4213
Carine El-SissyDepartment of Biological Immunology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Nadhir YousfiUnité Mixte de Recherche S1155, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.
Paula Vieira MartinsDepartment of Biological Immunology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Cédric RafatService de Soins Intensifs Néphrologiques et Rein Aigu (SINRA), French Intensive Renal Network, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Julien Masliah-PlanchonDepartment of Genetics, Institut Curie, PSL Research University, Paris, France.
Véronique Frémeaux-BacchiDepartment of Biological Immunology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Laurent MesnardUnité Mixte de Recherche S1155, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France. laurent.mesnard@aphp.fr.ORCID 0000-0002-0339-3757

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Complement Factor HGenetic Predisposition to DiseaseBlood ProteinsComplement C3b Inactivator ProteinsGenotypeHumansBlood ProteinsCFHR1 protein, humanCFHR3 protein, humanComplement C3b Inactivator ProteinsComplement Factor H

Identifiers

PMID37032353
PMCPMC10325998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.